Ekso Bionics (NASDAQ:EKSO) Earns Hold Rating from Analysts at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Ekso Bionics (NASDAQ:EKSO) in a note issued to investors on Thursday. The firm set a “hold” rating on the stock.

Separately, HC Wainwright raised their price target on shares of Ekso Bionics from $9.25 to $10.00 and gave the company a “buy” rating in a report on Tuesday, April 30th.

Ekso Bionics Stock Performance

EKSO opened at $1.04 on Thursday. Ekso Bionics has a 1-year low of $0.62 and a 1-year high of $3.13. The company has a 50 day simple moving average of $1.24 and a two-hundred day simple moving average of $1.62. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.81 and a quick ratio of 2.11. The firm has a market cap of $18.90 million, a P/E ratio of -1.07 and a beta of 1.49.

Ekso Bionics (NASDAQ:EKSO) last released its quarterly earnings results on Monday, April 29th. The company reported ($0.20) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.04). Ekso Bionics had a negative net margin of 79.48% and a negative return on equity of 95.36%. The business had revenue of $3.76 million for the quarter, compared to analysts’ expectations of $4.99 million. During the same period in the previous year, the company earned ($0.33) EPS. Equities analysts forecast that Ekso Bionics will post -0.43 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Ekso Bionics

A hedge fund recently raised its stake in Ekso Bionics stock. Kent Lake Capital LLC boosted its stake in Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) by 322.3% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 596,050 shares of the company’s stock after acquiring an additional 454,892 shares during the quarter. Kent Lake Capital LLC owned 3.28% of Ekso Bionics worth $811,000 as of its most recent filing with the SEC. 6.42% of the stock is owned by hedge funds and other institutional investors.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.